Takeda Pharmaceutical Company Ltd
🇯🇵Japan
- Country
- 🇯🇵Japan
- Ownership
- -
- Established
- 1925-01-01
- Employees
- -
- Market Cap
- $47.5B
- Website
- http://www.takeda.co.jp/
Efficacy of SYR-472 in Subjects With Type 2 Diabetes Mellitus
- First Posted Date
- 2008-04-04
- Last Posted Date
- 2016-06-22
- Lead Sponsor
- Takeda
- Target Recruit Count
- 369
- Registration Number
- NCT00653185
Efficacy and Safety of TAK-442 in Subjects Undergoing Total Knee Replacement
- First Posted Date
- 2008-03-24
- Last Posted Date
- 2016-04-13
- Lead Sponsor
- Takeda
- Target Recruit Count
- 1045
- Registration Number
- NCT00641732
Efficacy and Safety of Resatorvid in Patients With Sepsis-induced Cardiovascular and Respiratory Failure
- First Posted Date
- 2008-03-12
- Last Posted Date
- 2013-01-18
- Lead Sponsor
- Takeda
- Target Recruit Count
- 18
- Registration Number
- NCT00633477
A Safety and Tolerability Study of Peginesatide in Anemic Cancer Patients Receiving Cytotoxic Chemotherapy.
- First Posted Date
- 2008-03-06
- Last Posted Date
- 2011-12-01
- Lead Sponsor
- Takeda
- Target Recruit Count
- 2
- Registration Number
- NCT00629876
A Study of Dexlansoprazole Modified Release Formulation to Treat Night Heartburn
- First Posted Date
- 2008-02-29
- Last Posted Date
- 2011-04-28
- Lead Sponsor
- Takeda
- Target Recruit Count
- 305
- Registration Number
- NCT00627016
Efficacy of Ramelteon on Speeding Up Sleep in Subjects With Delayed Sleep Phase Syndrome
Phase 2
Completed
- Conditions
- Sleep Disorders, Circadian Rhythm
- Interventions
- Drug: Placebo
- First Posted Date
- 2008-01-15
- Last Posted Date
- 2012-02-28
- Lead Sponsor
- Takeda
- Target Recruit Count
- 132
- Registration Number
- NCT00593736
Efficacy and Safety Comparison of Azilsartan Medoxomil to Valsartan in Participants With Essential Hypertension
- First Posted Date
- 2008-01-11
- Last Posted Date
- 2012-02-02
- Lead Sponsor
- Takeda
- Target Recruit Count
- 984
- Registration Number
- NCT00591578
Efficacy and Safety of Azilsartan Medoxomil Co-Administered With Chlorthalidone in Participants With Essential Hypertension
Phase 3
Completed
- Conditions
- Hypertension
- Interventions
- First Posted Date
- 2008-01-11
- Last Posted Date
- 2011-04-19
- Lead Sponsor
- Takeda
- Target Recruit Count
- 551
- Registration Number
- NCT00591773
Efficacy and Safety of Azilsartan Medoxomil in African American Participants With Essential Hypertension
- First Posted Date
- 2008-01-11
- Last Posted Date
- 2011-04-19
- Lead Sponsor
- Takeda
- Target Recruit Count
- 413
- Registration Number
- NCT00591253
Efficacy and Safety of Azilsartan Medoxomil, Once Daily (QD), Co-Administered With Amlodipine in Participants With Essential Hypertension
Phase 3
Completed
- Conditions
- Hypertension
- Interventions
- First Posted Date
- 2008-01-11
- Last Posted Date
- 2011-07-22
- Lead Sponsor
- Takeda
- Target Recruit Count
- 566
- Registration Number
- NCT00591266
© Copyright 2025. All Rights Reserved by MedPath